Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

@article{Schutyser2005InvolvementOC,
  title={Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.},
  author={Evemie Schutyser and Ann Richmond and Jo Van Damme},
  journal={Journal of leukocyte biology},
  year={2005},
  volume={78 1},
  pages={14-26}
}
CC chemokine ligand 18 (CCL18) was originally discovered as pulmonary and activation-regulated chemokine (PARC), dendritic cell (DC)-chemokine 1 (DC-CK1), alternative macrophage activation-associated CC chemokine-1 (AMAC-1), and macrophage inflammatory protein-4 (MIP-4). CCL18 primarily targets lymphocytes and immature DC, although its agonistic receptor remains unknown so far. CCL18 is mainly expressed by a broad range of monocytes/macrophages and DC. A more profound understanding of the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 94 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 94 references

Inhibition of TNFduring maturation of dendritic cells results in the development of semimature DC: a potential mechanism by which TNF- blockade exerts its benificial effects in rheumatoid arthritis

  • T. W. van Lieshout, P. Barrera, +4 authors T. R. Radstake
  • Ann. Rheum. Dis
  • 2005

Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis (RA) and regulation by Fc receptors

  • T. R. Radstake, R. van der Voort, +8 authors G. J. Adema
  • Ann. Rheum. Dis
  • 2004

Similar Papers

Loading similar papers…